Literature DB >> 4899451

Glutaminase activity of L-asparagine amidohydrolase.

H K Miller, M E Balis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4899451     DOI: 10.1016/0006-2952(69)90329-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  On the validity of the steady state assumption of enzyme kinetics.

Authors:  L A Segel
Journal:  Bull Math Biol       Date:  1988       Impact factor: 1.758

2.  Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase.

Authors:  Wei-Wen Chien; Soraya Allas; Nicolas Rachinel; Pierre Sahakian; Michel Julien; Céline Le Beux; Claire-Emmanuelle Lacroix; Thierry Abribat; Gilles Salles
Journal:  Invest New Drugs       Date:  2014-05-15       Impact factor: 3.850

3.  L-glutamine as a substrate for L-asparaginase from Serratia marcescens.

Authors:  E K Novak; A W Phillips
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

4.  Molecular dynamic simulations of Escherichia coli L-asparaginase to illuminate its role in deamination of asparagine and glutamine residues.

Authors:  Rajeswara Reddy Erva; Satish Babu Rajulapati; Chandrasai Potla Durthi; Mayuri Bhatia; Madhuri Pola
Journal:  3 Biotech       Date:  2015-12-29       Impact factor: 2.406

Review 5.  Amino Acid Metabolic Vulnerabilities in Acute and Chronic Myeloid Leukemias.

Authors:  Aboli Bhingarkar; Hima V Vangapandu; Sanjay Rathod; Keito Hoshitsuki; Christian A Fernandez
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

6.  Unsatisfactory quality of E. coli asparaginase biogenerics in India: Implications for clinical outcomes in acute lymphoblastic leukaemia.

Authors:  Jasmeet Sidhu; Manash Pratim Gogoi; Praveen Agarwal; Tathagata Mukherjee; Debparna Saha; Priyanka Bose; Prakriti Roy; Yogesh Phadke; Bhatu Sonawane; Pritha Paul; Vaskar Saha; Shekhar Krishnan
Journal:  Pediatr Blood Cancer       Date:  2021-05-03       Impact factor: 3.838

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.